Circulating Levels of Bone and Inflammatory Markers in Gestational Diabetes Mellitus

about

Circulating Levels of Bone and Inflammatory Markers in Gestational Diabetes Mellitus

Item

http://www.wikidata.org/entity/Q58805499

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Circulating Levels of Bone and Inflammatory Markers in Gestational Diabetes Mellitus

@en

Circulating Levels of Bone and Inflammatory Markers in Gestational Diabetes Mellitus

@nl

type

Item

label

Circulating Levels of Bone and Inflammatory Markers in Gestational Diabetes Mellitus

@en

Circulating Levels of Bone and Inflammatory Markers in Gestational Diabetes Mellitus

@nl

prefLabel

Circulating Levels of Bone and Inflammatory Markers in Gestational Diabetes Mellitus

@en

Circulating Levels of Bone and Inflammatory Markers in Gestational Diabetes Mellitus

@nl

P1476

Circulating Levels of Bone and Inflammatory Markers in Gestational Diabetes Mellitus

@en

P2093

Adolfo Garcia-Ocana

http://www.w3.org/2001/XMLSchema#string

Carol J Levy

http://www.w3.org/2001/XMLSchema#string

Deirdre Cocks Eschler

http://www.w3.org/2001/XMLSchema#string

Georgia Kulina

http://www.w3.org/2001/XMLSchema#string

Jiawen Li

http://www.w3.org/2001/XMLSchema#string

Thomas Kraus

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

Maternal circulating concentrations of tumor necrosis factor-alpha, leptin, and adiponectin in gestational diabetes mellitus: a systematic review and meta-analysis

The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development

Relationship between serum RANKL and RANKL in bone

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy.

Loss of HGF/c-Met signaling in pancreatic β-cells leads to incomplete maternal β-cell adaptation and gestational diabetes mellitus.

Disruption of hepatocyte growth factor/c-Met signaling enhances pancreatic beta-cell death and accelerates the onset of diabetes

P304

123-130

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/BIORES.2018.0013

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30147996

http://www.w3.org/2001/XMLSchema#string

P921

gestational diabetes

P932

6106713

http://www.w3.org/2001/XMLSchema#string